Recent studies using transgenic mice expressing the human hCAP-18 gene demonstrated that LL-37 protects the lungs from bacterial infection and associated inflammation by significantly enhancing bacterial clearance and reducing the expression of key proinflammatory cytokines, such as IL-6 and IL-1β [44]. The gene discussed is CAMP; the disease is bacterial infectious disease.